BioCentury | Oct 21, 2019
Emerging Company Profile
Verseau unveils tumor macrophage reprogramming strategy
...collaboration project. Verseau’s investor syndicate includes 20/20 HealthCare Partners, 3SBio, Alexandria Venture Investments, Highlight Capital, InHarv Partners Ltd....
...Funds raised: $50 million Investors: 20/20 HealthCare Partners, 3SBio Inc., Alexandria Venture Investments, Highlight Capital, InHarv Partners Ltd....
...Funds raised: $50 million Investors: 20/20 HealthCare Partners, 3SBio Inc., Alexandria Venture Investments, Highlight Capital, InHarv Partners Ltd....
